3 studies found for:    golimumab, ulcerative colitis
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014179)
Condition: Ulcerative Colitis
Interventions: Biological: Golimumab, placebo;   Biological: golimumab, placebo;   Biological: Placebo
2 Terminated A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014188)
Condition: Ulcerative Colitis
Interventions: Biological: golimumab;   Biological: placebo
3 Completed A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014176)
Condition: Ulcerative Colitis
Interventions: Biological: Placebo;   Biological: Golimumab

Indicates status has not been verified in more than two years